{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:27:43Z","timestamp":1792114063919,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008530","name":"Fondo Europeo de Desarrollo Regional","doi-asserted-by":"publisher","award":["BIO2016-76063-R"],"award-info":[{"award-number":["BIO2016-76063-R"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"AGAUR","doi-asserted-by":"publisher","award":["2014SGR-132"],"award-info":[{"award-number":["2014SGR-132"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005053","name":"CIBER-BBN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Marat\u00f3 de TV3 Foundation","award":["TV32013-3930"],"award-info":[{"award-number":["TV32013-3930"]}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","award":["PI15\/00272"],"award-info":[{"award-number":["PI15\/00272"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","award":["PI15\/00378"],"award-info":[{"award-number":["PI15\/00378"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","award":["PIE15\/00028"],"award-info":[{"award-number":["PIE15\/00028"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Marat\u00f3 de TV3 foundation","award":["TV32013-2030"],"award-info":[{"award-number":["TV32013-2030"]}]},{"DOI":"10.13039\/501100003030","name":"AGAUR","doi-asserted-by":"publisher","award":["2014-PROD0005"],"award-info":[{"award-number":["2014-PROD0005"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"AGAUR","doi-asserted-by":"publisher","award":["2017FI_B100063"],"award-info":[{"award-number":["2017FI_B100063"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jconrel.2018.01.031","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T18:25:07Z","timestamp":1517423107000},"page":"81-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs"],"prefix":"10.1016","volume":"274","author":[{"given":"Laura","family":"S\u00e1nchez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naroa","family":"Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"\u00c1lamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Virtudes","family":"C\u00e9spedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f2nica","family":"Roldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"S\u00e1nchez-Chardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugutz","family":"Unzueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isolda","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Mangues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2615-4521","authenticated-orcid":false,"given":"Antonio","family":"Villaverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2018.01.031_bb0005","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.febslet.2009.03.029","article-title":"Venoms, venomics, antivenomics","volume":"583","author":"Calvete","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.toxicon.2011.03.017","article-title":"From snake venom toxins to therapeutics\u2014cardiovascular examples","volume":"59","author":"Koh","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0015","first-page":"228","article-title":"Deep sea as a source of novel-anticancer drugs: update on discovery and preclinical\/clinical evaluation in a systems medicine perspective","volume":"14","author":"Russo","year":"2015","journal-title":"EXCLI J."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0020","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2174\/0929867043364928","article-title":"Drugs from the sea: conopeptides as potential therapeutics","volume":"11","author":"Livett","year":"2004","journal-title":"Curr. Med. Chem."},{"issue":"Suppl. 4","key":"10.1016\/j.jconrel.2018.01.031_bb0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1179\/joc.2004.16.Supplement-1.86","article-title":"New drugs from the sea","volume":"16","author":"D'Incalci","year":"2004","journal-title":"J. Chemother."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0030","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.2174\/138161207782023739","article-title":"Approaching the golden age of natural product pharmaceuticals from venom libraries: an overview of toxins and toxin-derivatives currently involved in therapeutic or diagnostic applications","volume":"13","author":"Fox","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0035","first-page":"51","article-title":"New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials","volume":"7","author":"Kotova","year":"2015","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12934-016-0437-3","article-title":"Recombinant pharmaceuticals from microbial cells: a 2015 update","volume":"15","author":"Sanchez-Garcia","year":"2016","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.toxicon.2016.09.005","article-title":"Medical application of scorpion venom to breast cancer: a mini-review","volume":"122","author":"Sarfo-Poku","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0055","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.7150\/jca.15309","article-title":"Effects of animal venoms and toxins on hallmarks of cancer","volume":"7","author":"Chaisakul","year":"2016","journal-title":"J. Cancer"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.addr.2015.04.025","article-title":"Toxins and derivatives in molecular pharmaceutics: drug delivery and targeted therapy","volume":"90","author":"Zhan","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8070197","article-title":"Tumor targeting and drug delivery by anthrax toxin","volume":"8","author":"Bachran","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0070","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.3390\/toxins2112645","article-title":"Targeted toxins in brain tumor therapy","volume":"2","author":"Li","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/157488706776876454","article-title":"Clinical studies with targeted toxins in malignant glioma","volume":"1","author":"Rainov","year":"2006","journal-title":"Rev. Recent Clin. Trials"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2011.09.001","article-title":"Toxicology of nanoparticles","volume":"64","author":"Elsaesser","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0085","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1039\/C3AN90114A","article-title":"Editorial\u2014analytical toxicology of nanoparticles","volume":"139","author":"Haynes","year":"2014","journal-title":"Analyst"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mattod.2017.01.013","article-title":"Taking the vehicle out of drug delivery","volume":"20","author":"Shen","year":"2017","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11822","article-title":"PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery","volume":"7","author":"Zhao","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0100","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nnano.2014.208","article-title":"Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy","volume":"9","author":"Chung","year":"2014","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0105","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2217\/nnm-2016-0090","article-title":"Functional recruitment for drug delivery through protein-based nanotechnologies","volume":"11","author":"Vazquez","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0110","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1021\/mp200394t","article-title":"Nanomedicine(s) under the microscope","volume":"8","author":"Duncan","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0115","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1021\/nn4055732","article-title":"In vivo architectonic stability of fully de novo designed protein-only nanoparticles","volume":"8","author":"Cespedes","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201700919","article-title":"Peptide-based nanostructured materials with intrinsic proapoptotic activities in CXCR4+ solid tumors","volume":"27","author":"Serna","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0125","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0041-0101(01)00165-9","article-title":"Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century","volume":"39","author":"Collier","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0130","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3389\/fmicb.2015.00963","article-title":"Pseudomonas exotoxin a: optimized by evolution for effective killing","volume":"6","author":"Michalska","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0135","doi-asserted-by":"crossref","first-page":"17376","DOI":"10.1016\/S0021-9258(19)47383-3","article-title":"Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL","volume":"266","author":"Seetharam","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2018.01.031_bb0140","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1086\/315554","article-title":"Biology and molecular epidemiology of diphtheria toxin and the tox gene","volume":"181","author":"Holmes","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0145","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/07357900701360096","article-title":"Denileukin diftitox as novel targeted therapy for lymphoid malignancies","volume":"25","author":"Wong","year":"2007","journal-title":"Cancer Investig."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0150","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.molonc.2016.07.003","article-title":"Characterization of a re-engineered, mesothelin-targeted Pseudomonas exotoxin fusion protein for lung cancer therapy","volume":"10","author":"Bauss","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0155","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4143\/crt.2010.42.4.225","article-title":"The CXCR4 antagonist AMD3100 has dual effects on survival and proliferation of myeloma cells in vitro","volume":"42","author":"Kim","year":"2010","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0160","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3858\/emm.2010.42.6.048","article-title":"Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis","volume":"42","author":"Song","year":"2010","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1074\/jbc.M209548200","article-title":"Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake","volume":"278","author":"Richard","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbi.2016.08.015","article-title":"Chemokines and cocaine: CXCR4 receptor antagonist AMD3100 attenuates cocaine place preference and locomotor stimulation in rats","volume":"62","author":"Kim","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0175","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/hed.24461","article-title":"Antitumor effect of CXCR4 antagonist AMD3100 on the tumorigenic cell line of BHP10-3 papillary thyroid cancer cells","volume":"38","author":"Jung","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0180","first-page":"4533","article-title":"Intracellular CXCR4(+) cell targeting with T22-empowered protein-only nanoparticles","volume":"7","author":"Unzueta","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0185","doi-asserted-by":"crossref","first-page":"8714","DOI":"10.1016\/j.biomaterials.2012.08.033","article-title":"Non-amyloidogenic peptide tags for the regulatable self-assembling of protein-only nanoparticles","volume":"33","author":"Unzueta","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0190","first-page":"3530","article-title":"Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression","volume":"6","author":"Koshiba","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1387\/ijdb.041814hk","article-title":"The chemokine network in cancer\u2014much more than directing cell movement","volume":"48","author":"Kulbe","year":"2004","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jdermsci.2004.03.002","article-title":"Chemokine receptors and melanoma metastasis","volume":"36","author":"Murakami","year":"2004","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0205","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/426956","article-title":"Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target","volume":"2010","author":"Barbieri","year":"2010","journal-title":"J. Oncol."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0215","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1021\/nl052396o","article-title":"Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells","volume":"6","author":"Chithrani","year":"2006","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0220","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.1002\/adma.201503676","article-title":"Bottom-up instructive quality control in the biofabrication of smart protein materials","volume":"27","author":"Rueda","year":"2015","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0225","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1039\/C6NR09182B","article-title":"Intrinsic functional and architectonic heterogeneity of tumor-targeted protein nanoparticles","volume":"9","author":"Pesarrodona","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0230","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1080\/14740338.2016.1194824","article-title":"Drug-induced hepatotoxicity in cancer patients - implication for treatment","volume":"15","author":"Vincenzi","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0235","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s40264-016-0427-8","article-title":"Drug-induced liver injury: highlights from a review of the 2015 literature","volume":"39","author":"Sarges","year":"2016","journal-title":"Drug Saf."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0240","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/2141-9248.126619","article-title":"An evaluation of hepatotoxicity in breast cancer patients receiving injection Doxorubicin","volume":"4","author":"Damodar","year":"2014","journal-title":"Ann. Med. Health Sci. Res."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0245","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/CAD.0000000000000323","article-title":"Observation of hepatotoxicity during long-term gefitinib administration in patients with non-small-cell lung cancer","volume":"27","author":"Wang","year":"2016","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0250","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/ijc.30678","article-title":"Risk of hepatotoxicity in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis of published data","volume":"141","author":"Wang","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0255","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00042737-200406000-00013","article-title":"Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosis: the role of glucose intolerance","volume":"16","author":"Elefsiniotis","year":"2004","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0260","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2011.09.098","article-title":"The journey of a drug-carrier in the body: an anatomo-physiological perspective","volume":"161","author":"Bertrand","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0265","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2008.08.040","article-title":"Anatomical profiling of G protein-coupled receptor expression","volume":"135","author":"Regard","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0270","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7150\/thno.4835","article-title":"Molecular imaging of chemokine receptor CXCR4","volume":"3","author":"Weiss","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0275","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4161\/mabs.28965","article-title":"Comparative clinical pharmacokinetics of antibody-drug conjugates in first-in-human Phase 1 studies","volume":"6","author":"Deslandes","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0280","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.actbio.2017.07.027","article-title":"Protein-only, antimicrobial peptide-containing recombinant nanoparticles with inherent built-in antibacterial activity","volume":"60","author":"Serna","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0285","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-040210-162544","article-title":"Nanoparticle delivery of cancer drugs","volume":"63","author":"Wang","year":"2012","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2018.01.031_bb0290","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12934-016-0457-z","article-title":"Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli","volume":"15","author":"Rueda","year":"2016","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.jconrel.2018.01.031_bb0295","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.2217\/nnm-2016-0200","article-title":"CXCR4(+)-targeted protein nanoparticles produced in the food-grade bacterium Lactococcus lactis","volume":"11","author":"Cano-Garrido","year":"2016","journal-title":"Nanomedicine"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591830049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591830049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T17:48:33Z","timestamp":1660412913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836591830049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":59,"alternative-id":["S016836591830049X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.01.031","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}